MISSION PHARMACAL RXPORT
Mission Pharmacal Company
Trademark Registered: 2017-04-04
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86723111 |
| Registration Number | 5177239 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Pamela B. Huff |
| Attorney Docket Number | 4825.010US1 |
| Law Office Assigned | L50 |
| Employee Name | KUNKLEMAN, SARAH E |
Timeline
| 2015-07-31 | Date of First Use |
| 2015-08-12 | Application Filed |
| 2016-02-16 | Published for Opposition |
| 2017-03-01 | Location: PUBLICATION AND ISSUE SECTION |
| 2017-04-04 | Status: Live/Registered |
| 2017-04-04 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Mission Pharmacal Company |
| Address | 10999 IH-10 West, Suite 1000 San Antonio TX 78230 |
| Legal Entity Type | Corporation |
| Legal Entity State | TX |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 39 |
| U.S. Codes: | 100,105 |
| Type Code | Type |
|---|---|
| D10000 | "PHARMACAL" |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2015-08-17 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-08-18 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2015-11-24 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2015-11-30 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2015-11-30 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2015-11-30 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-12-05 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-12-05 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-12-10 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-12-21 | 10 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-01-27 | 11 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2016-02-16 | 12 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-02-16 | 13 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2016-04-12 | 14 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2016-10-12 | 15 EISU I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2016-10-12 | 16 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2016-11-01 | 17 AITU A:Allowance for Publication |
| EXTENSION 1 FILED | 2016-10-12 | 18 EXT1 S: |
| EXTENSION 1 GRANTED | 2016-11-01 | 19 EX1G S: |
| USE AMENDMENT FILED | 2016-10-12 | 20 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2016-11-01 | 21 SUPC I:Incoming Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-11-02 | 22 EXRA E:E-Mail |
| SU - NON-FINAL ACTION - WRITTEN | 2016-11-22 | 23 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2016-11-22 | 24 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-11-22 | 25 GNRN O:Outgoing Correspondence |
| SU-EXAMINER'S AMENDMENT WRITTEN | 2017-03-01 | 26 SNEA W: |
| EXAMINERS AMENDMENT E-MAILED | 2017-03-01 | 27 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-03-01 | 28 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2017-03-01 | 29 XAEC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2017-03-01 | 30 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2017-03-02 | 31 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2017-04-04 | 32 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2017-07-07 | 33 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-07-08 | 34 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-07-08 | 35 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-07-08 | 36 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-07-08 | 37 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-07-08 | 38 CHAN I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2021-03-03 | 39 ASCK I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2022-04-04 | 40 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2023-03-28 | 41 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-09-28 | 42 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2023-09-28 | 43 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2023-09-28 | 44 NA85 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MISSION PHARMACAL RXPORT 87365455 5322272 Live/Registered |
MISSION PHARMACAL COMPANY 2017-03-09 |
 MISSION PHARMACAL RXPORT 86723111 5177239 Live/Registered |
Mission Pharmacal Company 2015-08-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 